Chiron Real Estate Inc. | REIT Profile
Symbol: XRN
CIK: 1533615
Exchange: NYSE
Founded: 2011 (15 years)
HQ: Bethesda, MD, United States
Type of REIT: Equity REIT
Listing Status: Public
Market Capitalization: Small-Cap
REIT Sector: Health Care
Externally Managed REIT
REITRating™ Score: 3.3
See XRN on Yahoo Finance
See XRN on SEC.gov
 |
Chiron (KAI-ron), formerly Global Medical REIT, is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, we have built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
Stock Chart
Dividend of Trading Day 2026-08-19
Annualized Dividend: $0.64*
Dividend Yield (TTM): 2.2%
Annualized Dividend (TTM): $0.82
Ex-Dividend Date: 2026-08-20
Dividend Date: 2026-09-18
Dividend Frequency: Monthly
*The forward annualized dividend and dividend yield are based on the most recent dividend value paid by the REIT. The REIT may have already announced their next upcoming dividend value, which may be different from previously paid dividend value. It is recommended to check the REIT's website and dividend announcements for the latest information on upcoming dividends and changes. This graph does not include extraordinary dividend.
Latest REIT Press Releases
- Chiron - Chiron Real Estate Inc. Announces the Declaration of its October, November and December 2026 Common Dividends and Third Quarter Series A and Series B Preferred Dividends - Tue, 18 Aug 2026 20:05:26 UTC
- Chiron - Chiron Real Estate Inc. Announces Second Quarter 2026 Financial Results - Wed, 05 Aug 2026 20:06:01 UTC
- Chiron - Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08 - Mon, 03 Aug 2026 20:07:23 UTC
- Chiron - Chiron Real Estate Inc. Appoints Matthew Whitlock as Chief Investment Officer - Mon, 03 Aug 2026 20:05:21 UTC
- Chiron - Chiron Real Estate Inc. Strengthens Executive Leadership Team With Key Appointments - Tue, 14 Jul 2026 20:05:18 UTC
Key Stats of Trading Day 2026-08-19
EBITDA: $92,508,000 [?]
P/E (Price-to-Earnings) Ratio: 9.79 [?]
PEG (Price/Earnings to Growth) Ratio: 5.09 [?]
Book Value: 28.42 [?]
Dividend Per Share (DPS): $2.28 [?]
Earnings Per Share (EPS): 3.69 [?]
Revenue Per Share (TTM): $11.52 [?]
Profit Margin: 37.80% [?]
Operating Margin (TTM): 23.20% [?]
Return on Equity (TTM): 10.40% [?]
Revenue (TTM): $153,352,000 [?]
Gross Profit (TTM): $153,352,000 [?]
Diluted EPS (TTM): $3.69 [?]
Quarterly Earnings Growth YOY: N/A [?]
Quarterly Revenue Growth YOY: 4.80% [?]
Trailing P/E: 9.79 [?]
Forward P/E: 232.56 [?]
Beta: 1.13 [?]
Price-to-Book (P/B): 1.10 [?]
Enterprise Value (EV) to Revenue: 8.79 [?]
EV to EBITDA: 8.61x [?]
Shares Outstanding: 13,237,800 [?]
52 Week High: $38.49 [?]
52 Week Low: $27.58 [?]
50 Day Moving Average: $36.58 [?]
200 Day Moving Average: $35.04 [?]
REIT Simulation
Below is a simulation of how much money you would have made in dividends, and how much the shares would be worth had you purchased them 1 year ago for the amounts below.
| With $1,000 USD | With $500 USD | With $250 USD | With $100 USD | With $50 USD | |
|---|---|---|---|---|---|
| Initial investment | @ $34.27 per share you would have been able to buy 29 shares of XRN on 2025-08-20 costing $993.83 | @ $34.27 per share you would have been able to buy 14 shares of XRN on 2025-08-20 costing $479.78 | @ $34.27 per share you would have been able to buy 7 shares of XRN on 2025-08-20 costing $239.89 | @ $34.27 per share you would have been able to buy 2 shares of XRN on 2025-08-20 costing $68.54 | @ $34.27 per share you would have been able to buy 1 shares of XRN on 2025-08-20 costing $34.27 |
| Current worth | On 2026-08-19 these 29 shares would be worth $1,070.25 @ $36.91 | On 2026-08-19 these 14 shares would be worth $516.67 @ $36.91 | On 2026-08-19 these 7 shares would be worth $258.34 @ $36.91 | On 2026-08-19 these 2 shares would be worth $73.81 @ $36.91 | On 2026-08-19 these 1 shares would be worth $36.91 @ $36.91 |
| Dividends earned | $88.45 in dividends would have been earned since 2025-08-20 with 29 shares. | $43 in dividends would have been earned since 2025-08-20 with 14 shares. | $21.35 in dividends would have been earned since 2025-08-20 with 7 shares. | $6.10 in dividends would have been earned since 2025-08-20 with 2 shares. | $3.05 in dividends would have been earned since 2025-08-20 with 14 shares. |
| Net (gain / loss)* | 164.87 USD | 79.59 USD | 39.80 USD | 11.37 USD | 5.69 USD |
| ROI** | 16.59% | 16.59% | 16.59% | 16.59% | 16.59% |
*Net (Gains/Loss): Includes the stock price (appreciate or depreciate ) + dividends earned during period held. Stock prices based on closing price for the date. **ROI: Is based on the Net (gain/loss) divided by the initial investment value. Note: Past performance is no guarantee of future results. This is a high-level simulation and does not account for many factors such as inflation and taxes so we cannot guarantee the accuracy of this simulation.
Dividend History
Below are the most recent cash dividends paid by XRN. The percent difference from one dividend payment to the next has also been calculated for your convenience. Dividends flagged as [E] are extraordinary dividend payments.
| Symbol | Ex Date | Cash Amount | Change in Dividend | Declaration Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| XRN | 2026-11-20 | 0.160 | --- | 2026-08-18 | 2026-11-20 | 2026-12-18 |
| XRN | 2026-10-20 | 0.160 | --- | 2026-08-18 | 2026-10-20 | 2026-11-13 |
| XRN | 2026-09-21 | 0.160 | --- | 2026-08-18 | 2026-09-21 | 2026-10-16 |
| XRN | 2026-07-20 | 0.160 | --- | 2026-05-05 | 2026-07-20 | 2026-08-14 |
| XRN | 2026-06-22 | 0.160 | -36.00% | 2026-05-05 | 2026-06-22 | 2026-07-17 |
| XRN | 2026-05-20 | 0.250 | --- | 2026-02-24 | 2026-05-20 | 2026-06-12 |
| XRN | 2026-04-20 | 0.250 | --- | 2026-02-24 | 2026-04-20 | 2026-05-15 |
| XRN | 2026-03-20 | 0.250 | -66.67% | 2026-02-24 | 2026-03-20 | 2026-04-17 |
| XRN | 2025-12-19 | 0.750 | --- | 2025-12-04 | 2025-12-19 | 2026-01-09 |
| XRN | 2025-09-29 | 0.750 | 400.00% | 2025-09-03 | 2025-09-29 | 2025-10-15 |
| XRN | 2025-06-20 | 0.150 | -28.57% | 2025-05-28 | 2025-06-20 | 2025-07-09 |
| XRN | 2025-03-21 | 0.210 | --- | 2025-02-27 | 2025-03-21 | 2025-04-09 |
Financial Statements Overview
Balance Sheet | Quarterly
| Assets | 2026-06-30 | 2026-03-31 | QoQ |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents at Carrying Value | 10,658,000 | 8,183,000 | |
| Short-Term Investments | 0 | 0 | |
| Cash and Short Term Investments | 10,658,000 | 8,183,000 | |
| Current Net Receivables | 3,024,000 | 6,800,000 | |
| Inventory | 0 | 0 | |
| Other Current Assets | 0 | 0 | |
| Total Current Assets | 13,682,000 | 14,983,000 | -8.7% |
| Non-Current Assets | |||
| Property Plant Equipment | 0 | 0 | |
| Accumulated Depreciation Amortization PPE | 0 | 0 | |
| Long-Term Investments | 0 | 0 | |
| Investments | 0 | 0 | |
| Intangible Assets Excluding Goodwill | 140,461,000 | 144,573,000 | |
| Goodwill | 5,903,000 | 5,903,000 | |
| Intangible Assets | 140,461,000 | 144,573,000 | |
| Other Non-Current Assets | 0 | 0 | |
| Total Non-Current Assets | 146,364,000 | 150,476,000 | -2.7% |
| Total Assets | 1,371,778,000 | 1,238,019,000 | 10.8% |
| Liabilities | |||
| Current Liabilities | |||
| Current Accounts Payable | 0 | 0 | |
| Deferred Revenue | 0 | 0 | |
| Current Debt | 0 | 0 | |
| Short-Term Debt | 0 | 0 | |
| Current Long-Term Debt | 0 | 0 | |
| Short Long-Term Debt Total | 0 | 0 | |
| Other Current Liabilities | 0 | 0 | |
| Total Current Liabilities | 0 | 0 | 0.0% |
| Non-Current Liabilities | |||
| Long-Term Debt Noncurrent | 0 | 0 | |
| Long-Term Debt | 0 | 0 | |
| Capital Lease Obligations | 0 | 0 | |
| Other Non-Current Liabilities | 0 | 0 | |
| Total Non-Current Liabilities | 0 | 0 | |
| Total Liabilities | 687,713,000 | 717,369,000 | -4.1% |
| Shareholders' Equity | |||
| Common Stock | 13,000 | 13,000 | |
| Common Stock Shares Outstanding | 13,235,000 | 13,235,000 | |
| Treasury Stock | 0 | 0 | |
| Retained Earnings | -303,703,000 | -360,640,000 | |
| Total Shareholder Equity | 656,947,000 | 500,211,000 | 31.3% |
Amounts in USD ($)
Income Statement | Quarterly
| 2026-06-30 | 2026-03-31 | QoQ | |
|---|---|---|---|
| Total Revenue | 39,747,000 | 38,064,000 | 4.4% |
| Cost of Revenue | 0 | 0 | |
| Cost of Goods and Services Sold | 0 | 0 | |
| Gross Profit | 0 | 0 | 0.0% |
| Research and Development | 0 | 0 | |
| Selling General and Administrative | 5,221,000 | 5,089,000 | |
| Depreciation | 0 | 0 | |
| Depreciation and Amortization | 0 | 0 | |
| Operating Expenses | 10,034,000 | 9,250,000 | |
| Operating Income | 0 | 0 | 0.0% |
| EBIT (Earnings Before Interest and Tax) | 0 | 0 | |
| Investment Income Net | 0 | 0 | |
| Net Interest Income | 0 | 0 | |
| Interest Income | 0 | 0 | |
| Interest Expense | 8,806,000 | 7,233,000 | |
| Interest and Debt Expense | 0 | 0 | |
| Non Interest Income | 0 | 0 | |
| Other Non Operating Income | 0 | 0 | |
| Income Before Tax | 63,290,000 | -749,000 | -8,549.9% |
| Income Tax Expense | 0 | 0 | |
| Net Income from Continuing Operations | 0 | 0 | |
| Net Income | 63,290,000 | -749,000 | -8,549.9% |
| Comprehensive Income Net of Tax | 0 | 0 | |
| EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) | 0 | 0 |
Amounts in USD ($)
Cash Flow | Quarterly
| Cash Flows from Operating Activities | 2026-06-30 | 2026-03-31 | QoQ |
|---|---|---|---|
| Net Income | 74,684,000 | 1,724,000 | 4,232.0% |
| Depreciation, Depletion, and Amortization | 14,952,000 | 14,827,000 | |
| Change in Receivables | 0 | 0 | |
| Change in Inventory | 0 | 0 | |
| Change in Operating Assets | 0 | 0 | |
| Change in Operating Liabilities | 0 | 0 | |
| Payments for Operating Activities | 0 | 0 | |
| Proceeds from Operating Activities | 0 | 0 | |
| Profit Loss | 0 | 0 | |
| Net Cash Provided by Operating Activities | 22,557,000 | 0 | 0.0% |
| Cash Flows from Investing Activities | |||
| Capital Expenditures | 0 | 0 | |
| Net Cash Used in Investing Activities | -71,872,000 | 0 | |
| Cash Flows from Financing Activities | |||
| Proceeds from Issuance of Common Stock | 0 | 0 | |
| Proceeds from Issuance of Preferred Stock | 0 | 0 | |
| Proceeds from Issuance of Long-Term Debt | 0 | 0 | |
| Proceeds from Repurchase of Equity | 0 | 0 | |
| Proceeds from Sale of Treasury Stock | 0 | 0 | |
| Repayment of Short-Term Debt | 0 | 0 | |
| Payments for Repurchase of Common Stock | 0 | 0 | |
| Payments for Repurchase of Preferred Stock | 0 | 0 | |
| Payments for Repurchase of Equity | 0 | 0 | |
| Dividend Payout | 10,862,000 | 0 | |
| Dividend Payout - Common Stock | 10,862,000 | 0 | |
| Dividend Payout - Preferred Stock | 0 | 0 | |
| Net Cash Provided by Financing Activities | 51,275,000 | 0 | 0.0% |
| Other Items | |||
| Effect of Exchange Rate on Cash | 0 | 0 | |
| Net Increase in Cash and Cash Equivalents | 0 | 0 |
Amounts in USD ($)
REITRating™ Scorecard
Compare with other REITs | See the complete trend
| Rating | Dividend Section | Avg. Rating |
|---|---|---|
| 0 | Dividend Payment Consistency: Analysis of how many periods the REIT’s dividends have been paid consistently without a gap in payment. | 8.1 |
| Rating | AFFO & Efficiency Section | Avg. Rating |
| 10 | Operating Expense Efficiency: Analysis of the REIT's Operating Expenses to its Revenues. | 9.6 |
| 8 | Operating Expense Efficiency Trend: Analysis of the trend of the REIT's Operating Expenses to its Revenue. | 8.6 |
| Rating | Leverage Section | Avg. Rating |
| 6 | Debt Leverage Health: Analysis of the REIT’s Total Debt to Total Assets. | 5.0 |
| 9 | Debt Leverage Health Trend: Analysis of the REIT’s Total Debt to Total Assets over the last two years. | 6.7 |
| Rating | Asset & Revenue Section | Avg. Rating |
| 5 | G&A Effeciency Level: Analysis of the REIT’s General and Administrative expenses in relationship to its Revenues. | 6.8 |
| 7 | G&A Effeciency Trend: Analysis of the Trend of the REIT’s General and Administrative expenses in relationship to its Revenues. | 7.3 |
| 7 | Revenues Growth: Analysis of how the REIT's Revenue has performed over the last two years. | 7.1 |
| 6 | Total Asset Growth: Analysis of how the REIT has grown its Total Assets over the last two years. | 6.2 |
| Rating | Properties Section | Avg. Rating |
| Rating | Market Cap Section | Avg. Rating |
| 3.3 | Overall REITRating™ Score (See trend) | 5.2 |
REITRating is REITNote's Real Estate Investment Trust industry-specific rating and ranking system. The REIT’s score for each analysis is out of ten points, with ten being the best score and zero being the worst. A score of zero can be assigned if the REIT does not meet the criteria for that specific analysis. N/A is assigned if insufficient data is available for a particular analysis. Our REITRating logic is continuously improving, so a REIT’s rating and ranking may change over time. Important Note: REITRating is not a predictor of a REIT’s future performance, it is an evaluation of its past results. Additionally, the REITRating system is for informational purposes only and does not represent financial or investment advice or a recommendation of which REITs to acquire. Learn more.
Related REITs
| REIT | REITRating™ Score | Exchange | Market Capitalization | Sector | Country |
|---|---|---|---|---|---|
| Centerspace (CSR) | 7.2 | NYSE | Small-Cap | Diversified Residential Office Retail Health Care | United States |
| Community Healthcare Trust (CHCT) | 7.5 | NYSE | Small-Cap | Health Care | United States |
| Diversified Healthcare Trust (DHC) | 4.7 | NASDAQ | Small-Cap | Health Care | United States |
| Gladstone Commercial Corporation, Inc. (GOOD) | 6.6 | NASDAQ | Small-Cap | Diversified Industrial Office Health Care Retail | United States |
| National Healthcare Properties, Inc. (NHP) | N/A | NASDAQ | Small-Cap | Health Care | United States |
Last updated: 2026-08-20 - v7.2.2